statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Around 70% of stocks in Nifty MidCap 100 and Nifty SmallCap 100 indices witnessed a rise in mutual fund stakes in December 2023 quarter, according to Ace Equities data.

MFs raise stakes in 70% Nifty smallcap, midcap stocks in Q3, despite caution

Prabhudas Lilladher recommended hold rating on Jubilant Ingrevia with a target price of Rs 433 in its research report dated January 30, 2024.

Hold Jubilant Ingrevia; target of Rs 433: Prabhudas Lilladher

Net Sales are expected to decrease by 22 percent Y-o-Y (down 11.4 percent Q-o-Q) to Rs. 903.8 crore, according to Prabhudas Lilladher.

Jubilant Ingrevia Q3 PAT may dip 48.8% YoY to Rs. 46.8 cr: Prabhudas Lilladher

Jubilant Ingrevia Ltd. engages in the provision of life science products and solutions. The company operates through the following segments: Speciality Chemicals, Nutrition and Health Solutions, and Life Science Chemicals. The Speciality Chemicals segment manufactures pyridine and picolines, fine chemicals, and agro chemicals. The Nutrition and Health Solutions segment offers nutrition and health ingredients, as well as animal and human nutrition health solutions. The Life Science Chemicals segment includes acetyls and specialty ethanol. The company was founded in 2019 and is headquartered in Noida, India.

Jubilant Ingrevia Ltd.

52-Wk High	581.70
52-Wk Low	379.05

JUBLINGREA.NSE Jubilant Ingrevia Ltd.

About

Feed

News

Sentiment

Fundamentals